Large YoY Increase in Reported Net Income (Non‑Cash Driven)
Net income was $0.52 per diluted share in Q4 2025 versus $0.043 in Q4 2024 — an increase of approximately +1,100%, primarily driven by unrealized gains on preferred stock and stock warrant investments (non‑cash).
Dividend Maintained and Covered by CAD
Paid a regular dividend of $0.50 per share in Q4; coverage by cash available for distribution (CAD) was 1.06x. The Board declared a $0.50 per share dividend for 2026, indicating consistency in shareholder payout policy.
Improved Cash Available for Distribution and Book Value
Cash available for distribution (CAD) was $0.53 per diluted share, up from $0.47 in the prior quarter (+12.8% quarter‑over‑quarter). Book value per share rose 1.4% from Q3 to $19.10 per diluted share, driven by unrealized gains on preferreds and warrants.
Active New Loan Originations with Attractive Yields
Funded new loans including $5.7M at SOFR +900bps (14% floor), $22.5M at an 11% monthly coupon, and $17.4M across two marina loans at a 13% monthly coupon — demonstrating continued deployment into higher‑yielding senior and preferred positions.
Capital Markets Execution and Balance Sheet Actions
Raised $60.5M gross from a Series B preferred offering and launched an 8% Series C preferred (approximately $14.1M raised to date). Executed a re‑REMIC transaction that reduces mark‑to‑market repo financing and is expected to be accretive to annual CAD by ~$0.30–$0.34 per share.
Portfolio Outperformance in Self‑Storage and Life Science Momentum
NexPoint storage portfolio finished 2025 at 91.7% occupancy, exceeded NOI budget by 3.2% and grew NOI +13% versus 2024. Alewife life‑science asset is 64% leased with RFPs/LOIs/leases equal to 2.8x the project's square footage and a current 9% debt yield, with management expecting full lease‑up in 2026 and a ~12% debt yield when stabilized.